Metabolic fate of extracellular NAD in human skin fibroblasts by ALEO M.F et al.
Journal of Cellular Biochemistry 80:360±366 (2001)
Metabolic Fate of Extracellular NAD in Human Skin
Fibroblasts
Maria Francesca Aleo,1* Maria Luisa Giudici,1 Silvia Sestini,2 Paola Danesi,1 Giuseppe Pompucci,2
and Augusto Preti1
1Departament of Biomedical Science and Biotechnology, University of Brescia, 25123 Brescia, Italy
2Department of Molecular Biology, University of Siena, 53100 Siena, Italy
Abstract Extracellular NAD is degraded to pyridine and purine metabolites by different types of surface-located
enzymes which are expressed differently on the plasmamembrane of various human cells and tissues. In a previous
report, we demonstrated that NAD-glycohydrolase, nucleotide pyrophosphatase and 50-nucleotidase are located on the
outer surface of human skin ®broblasts. Nucleotide pyrophosphatase cleaves NAD to nicotinamide mononucleotide and
AMP, and 50-nucleotidase hydrolyses AMP to adenosine. Cells incubated with NAD, produce nicotinamide, nicoti-
namide mononucleotide, hypoxanthine and adenine. The absence of ADPribose and adenosine in the extracellular
compartment could be due to further catabolism and/or uptake of these products. To clarify the fate of the purine moiety
of exogenous NAD, we investigated uptake of the products of NAD hydrolysis using U-[14C]-adenine-NAD. ATP was
found to be the main labeled intracellular product of exogenous NAD catabolism; ADP, AMP, inosine and adenosine
were also detected but in small quantities. Addition of ADPribose or adenosine to the incubation medium decreased
uptake of radioactive purine, which, on the contrary, was unaffected by addition of inosine. ADPribose strongly
inhibited the activity of ecto-NAD-hydrolyzing enzymes, whereas adenosine did not. Radioactive uptake by purine
drastically dropped in ®broblasts incubated with 14C-NAD and dipyridamole, an inhibitor of adenosine transport. Partial
inhibition of [14C]-NAD uptake observed in ®broblasts depleted of ATP showed that the transport system requires ATP to
some extent. All these ®ndings suggest that adenosine is the purine form taken up by cells, and this hypothesis was
con®rmed incubating cultured ®broblasts with 14C-adenosine and analyzing nucleoside uptake and intracellular
metabolism under different experimental conditions. Fibroblasts incubated with [14C]-adenosine yield the same
radioactive products as with [14C]-NAD; the absence of inhibition of [14C]-adenosine uptake by ADPribose in the
presence of a-b methyleneADP, an inhibitor of 50 nucleotidase, demonstrates that ADPribose coming from NAD via
NAD-glycohydrolase is ®nally catabolised to adenosine. These results con®rm that adenosine is the NAD hydrolysis
product incorporated by cells and further metabolized to ATP, and that adenosine transport is partially ATP dependent.
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In all living cells, nicotinamide adenine
dinucleotide (NAD) is a cofactor for redox-reac-
tions and substrate for enzymes such as mono
and poly-ADP-ribosyl transferase [Ueda and
Hayaishi, 1985], ADP-ribosyl cyclase [Lee and
Aarhus, 1991] and NAD-glycohydrolase [Travo
et al., 1979]. NAD has also been identi®ed as a
synaptic modulator in the central nervous
system [Snell et al., 1984] and as an inhibitor
of excitatory synaptic transmission in the rat
hippocampus, acting through activation of spe-
ci®c receptors [Gallareta et al., 1993]. This evi-
dence associated with the presence of NAD in
biological ¯uids [Kim et al., 1993a; Majamaa
et al., 1996; De Flora et al., 1996] has revealed
much about the physiological functions of this
nucleotide.
Extracellular NAD is degraded to pyridine
and purine metabolites by different types of
surface-located enzymes, which are expressed
differently on the plasmamembrane of various
human cells and tissues [Zimmermann, 1996;
Han et al., 1995]. The main enzyme family is
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the NAD-glycohydrolases. It is NAD speci®c
and hydrolyses NAD to nicotinamide and
ADPribose [Bock et al., 1971; Muller et al.,
1983; Honma and Mandel, 1986]. In blood cells
NAD-glycohydrolase activity is expressed by
the transmembrane glycoprotein CD38 [Mala-
vasi et al., 1994], a bifunctional ectoenzyme
converting NAD to nicotinamide and cyclic
ADPribose (ADP-ribosyl cyclase activity) and
cyclic ADPribose to ADPribose (cADPribose
hydrolase activity) [Zocchi et al., 1993; Kim
et al., 1993b]. Cyclic ADPribose is a newly
identi®ed messenger which mobilizes Ca2
from an inositol 1,4,5-trisphosphate insensitive
intracellular store [Berridge, 1993; Lee, 1994;
De Flora et al., 1998]. NAD therefore acts as
extracellular signaling substance or is a pre-
cursor of signaling nucleotides [Kato et al.,
1995; Okamoto et al, 1995]. A number of enzy-
mes metabolizing extracellular purine nuc-
leotides and nucleosides may also act on
exogenous NAD, in¯uencing its physiological
role and the fate of the hydrolysis products
[Zimmermann, 1996].
In a previous report [Aleo et al., 1996], we
demonstrated that NAD-glycohydrolase, nuc-
leotide pyrophosphatase and 50-nucleotidase
are located on the outer surface of human skin
®broblasts. Nucleotide pyrophosphatase clea-
ves NAD to nicotinamide mononucleotide and
AMP, and 50-nucleotidase hydrolyses AMP to
adenosine. Cells incubated in the presence of
NAD, produced nicotinamide, nicotinamide
mononucleotide (NMN), hypoxanthine and ad-
enine but not ADPribose and adenosine (prob-
ably due to uptake and further catabolism of
these products).
To clarify the fate of the purine moiety of
exogenous NAD and its role in the intracellular
metabolism of purines, we investigated the up-
take and reutilization of NAD-hydrolysis pro-
ducts, using U-[14C]-adenine-NAD.
METHODS
Materials
Minimum essential medium with Earle's
salts (MEM), glutamine, trypsin, and foetal
calf serum were from Life Technologies Italia
S.r.l. (Gibco BRL). NAD, adenine, adenosine,
ADPribose, AMP, ADP, ATP, IMP, inosine,
hypoxanthine, dipyridamole, nitrobenzylthioi-
nosine, 2-deoxy-D-glucose, ouabaine, 1,N6-
etheno-NAD and methyleneadenosine 50-dip-
hosphate were from Sigma-Aldrich S.r.l.
(Milan, Italy). NaN3 was from Merck (Bracco
S.p.A, Milan, Italy). Methanol and tetrabuty-
lammonium dihydrogen phosphate (TBA) were
from Carlo-Erba (Milan, Italy).
Cell Culture
Human skin ®broblasts were grown in
35 mm dishes containing MEM medium with
10% foetal calf serum and 2 mM L-glutamine in
a 5% CO2 atmosphere at 37
C.
Enzyme Assays
Ecto-NAD-hydrolyzing activities (NAD-gly-
cohydrolase and nucleotide pyrophosphatase)
were measured by a ¯uorimetric method des-
cribed by Muller et al. [1983]: con¯uent ®bro-
blasts were incubated 10 min at 37C in the
presence of 0.2 mM 1,N6-etheno-NAD in 500 ml
phosphate buffered saline (PBS); 400ml of
incubation medium was diluted with the same
volume of PBS and ¯uorescence measured. In
some experiments, 1 mM ADPribose or adeno-
sine or 5 mM NaN3 and 50 mM 2-deoxyglucose
(NaN3/dxg) were added to the incubation medi-
um. Fluorescence was measured using a Jasco
FP-770 Spectro¯uorimeter exciting at 290 nm
and reading at 415 nm.
Determination of ATP in Controls and
ATP-Depleted Cells
Depletion of ATP intracellular levels was
achieved incubating ®broblasts at 37C with
10 mM Hepes in Hank's buffer pH 7.4 (H/H
buffer) without glucose but containing NaN3/
dxg. After 15, 30, 75 and 90 min, cells were
harvested by scraping in 0.1 N HClO4, the cell-
ular extracts centrifuged for 15 min at 12,000 g
in an Eppendorf 5414 centrifuge and the super-
natants neutralized with 1.33 M K2CO3. The
ATP, ADP and AMP contents of the ®nal clear
supernatant were analyzed by HPLC. Protein
determination was performed by Bradford
assay [Bradford, 1976] on the ®rst pellet resus-
pended in 1 M NaOH. Control cells were incu-
bated for the same times with H/H buffer.
HPLC analysis was performed as previously
described [Aleo et al. 1996] using 0.1 M K-phos-
phate buffer containing 6 mM TBA at pH 5.5
and methanol as eluants.
14C-NAD and 14C-Adenosine Supply
Con¯uent ®broblasts were incubated for
60 min at 37C with 1 mM U-[14C]-adenine-
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NAD (252 mCi/mmol, Amersham International
plc, England) or 1 mM 8-[14C] adenosine
(58 mCi/mmol NEN Life Science Products Italy
S.r.l.) in H/H buffer. The reaction was stopped
by chilling cells at 0C. After washing, cells
were harvested by scraping with 70% (v/v) eth-
anol and centrifuged for 10 min at 14,000 g in a
Hermle Z 230 MA centrifuge. Pellets were re-
suspended with 1 volume of 18% trichloroacetic
acid and dissolved with 2 volume of 1 M NaOH,
while supernatants were evaporated to 80ml in
a speed-vac centrifuge (Howe, Gyrovap L) and
then used for thin layer chromatography ana-
lysis. Aliquots of supernatant or pellet were
measured in a Wallac Win Spectral TM 1414
Liquid Scintillation Counter.
ADPribose or adenosine or inosine or dipyr-
idamole (DPR) or nitrobenzylthioinosine (NBT)
(100 mM) were added to the incubation medium
where indicated.
Protein content of NaOH dissolved pellets
was determined according to Bradford [Brad-
ford, 1976] using bovine serum albumin as
standard.
TLC Analysis and Autoradiography
The labeled products were estimated by
TLC using iso-butyric acid/H2O/NH3 (66:33:1.7
v/v/v) as solvent system. Suitable unlabeled
internal standards were used and visualised
by UV ¯uorescence. Autoradiography of plates
was detected with Hyper®lm-MP X-ray
(Amersham) and the radioactive spots were
scraped and quanti®ed by liquid scintillation
count.
RESULTS
When human skin ®broblasts were incuba-
ted 60 min at 37C with H/H buffer containing
1 mM U-[14C]-adenine-NAD (150 nCi/dish),
25 3.0% of the total radioactivity, or
1.27 0.1 nmol/mg protein, was incorporated
by the cells (n 12). TLC analysis of cell
extracts revealed that the labeled species were
mainly ATP (79.97%) and ADP plus IMP
(11.86%); trace amounts of NAD (1.45%),
AMP (1.67%) and other purines such as adeno-
sine, inosine and hypoxanthine (2.17, 2.23, and
0.64%, respectively) were also present.
The main purine products of extracellular
NAD hydrolysis in ®broblasts [Aleo et al.,
1996], namely ADPribose and adenosine were
then added to the incubation medium contain-
ing U-[14C]-adenine-NAD. Total radioactive
cell uptake drastically decreased to 3.6 0.9%
in the presence of ADPribose and 5.0 0.76%
in the presence of adenosine (n 5), while
the relative proportion of intracellular labeled
compounds did not vary with respect to control
cells (Fig. 1). Thus, extracellular ADPribose
and adenosine interfere in the uptake of
radioactivity, but do not modify 14C-purine
recycling.
ADPribose is a known inhibitor of NAD gly-
cohydrolase [Honma and Mandel, 1986] and it
competes with NAD as a substrate of nucleo-
tide pyrophosphatase. When added to the
incubation medium of the NAD-hydrolytic
ectoenzyme assay, ADPribose strongly inhib-
ited their activity, but adenosine did not (Table
I). This suggests that ADPribose and adenosine
affect [14C]NAD uptake differently: ADPribose
competes with [14C]NAD in the production of
the radioactive purine moiety, which is then
only partially taken up, whereas adenosine
competes directly with the latter compound for
membrane passage, without affecting the
ectoenzymes.
Uptake of the 14C-purine moiety was also
measured in the presence of the purine nucleo-
side inosine, or DPR, an inhibitor of adenosine
transport. Uptake was reduced to 2.1 0.6%
per 100 mM DPR, and 19.5 2.4% per 100 mM
inosine (n 4). All these results suggest that
adenosine is the molecule involved in purine
moiety uptake by NAD.
Fig. 1. Distribution of intracellular radioactive adenine com-
pounds after incubation of ®broblasts for 1 h with 1 mM U-[14C]-
adenine-NAD in the presence or absence of 100mM ADPribose
or adenosine. Values are given as percentage of total cell extract
radioactivity.
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Effect of ATP Depletion on
U-[14C]-Adenine-NAD Uptake
The effect of ATP depletion on radioactivity
uptake was also examined. When ®broblasts
were incubated with H/H buffer without glu-
cose, with 5 mM NaN3 and 50 mM deossyglu-
cose, 73% of the energy charge of the adenylate
pool, as de®ned by Atkinson formula [Atkinson,
1977], was lost after 15 min and reached a
minimum (9%) after 75 min. Figure 2 shows the
time course of cell content of AMP, ADP and
ATP assayed by HPLC. After 15 min of NaN3/
dxg treatment, 1 mM [14C]NAD was added and
60 min later the radioactivity of cell extracts
was measured. These ATP-depletion conditions
reduced the uptake of total 14C-purine to
13.0 1.5%, which is 54.7 5.3% (n 6) of the
value found in untreated controls, and modi®ed
intracellular radioactivity distribution (Fig. 3).
The recycling of labeled purine matches the
behavior of adenine nucleotides observed in
time-course experiments: ATP production was
inhibited, and AMP accumulated. The activ-
ities of NAD hydrolyzing ectoenzymes were not
affected by incubation with NaN3/dxg (Table I).
These results suggest that transport of U-[14C]-
adenine-NAD requires ATP to some extent.
[14C]-Adenosine Uptake
To con®rm that adenosine is the NAD moiety
responsible for [14C]-purine uptake, ®broblasts
were incubated in the presence of 1 mM 8-[14C]-
adenosine (35 nCi/dish). Uptake of [14C]-adeno-
sine was linear with time for at least 30 min,
TABLE I. Assay of Membrane NAD-Hydrolase Activities
(NAD-Glycohydrolase and Nucleotide Pyrophosphatase)
in Human Skin Fibroblasta
ADPribose Adenosine NaN3 (5 mM)
Control (1 mM) (1 mM) dxg (50 mM)*
184,3036,60 00,00 0,00 146,70 15,00 166,30 10,30
(n6) (n6) (n4) (n5)
aCells were incubated for 10 min at 37C in the presence of 0.2 mM 1,N6-
etheno-NAD with or without ADPribose or Adenosine or NaN3/dxg (in the
indicated amounts). Activity is expressed as ¯uorescence units (DF/min) per mg
of protein.
*Cells were preincubated for 15 min at 37C in 10 mM Hanks'/Hepes buffer
pH 7.4 without glucose and in the presence of NaN3/dxg before addition of 1,N6-
etheno-NAD.
Fig. 2. Time course of ATP, ADP and AMP content in cell
extract (nmol/mg of protein), after incubation with 5 mM NaN3
and 50 mM dxg in H/H buffer without glucose. Data of a
representative experiment, made in duplicate, are shown.
Fig. 3. Distribution of radioactive adenine compounds in cell
extract of ATP-depleted ®broblasts. Cells were incubated for
15 min in H/H buffer without glucose containing NaN3/dxg,
then 1 mM U-[14C]-adenine-NAD was added and after 1 h the
radioactivity of the different adenine compounds was measured.
Control cells were incubated in H/H without NaN3/dxg. Values
are given as percentage of total cell extract radioactivity.
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reaching 1.46 0.26 nmol/mg protein at 60 min
(33.7 5.6% of total radioactivity, n 10),
when cell extract radioactivity showed a same
pattern of purine compounds identical to that
detected after incubation with [14C]NAD (Fig.
4). [14C]-adenosine uptake was completely
depressed by two inhibitors of equilibrative
nucleoside transport, namely 10mM DPR or
10 mM NBT; being 1.64 0.8 and 1.2 0.1% of
total radioactivity, respectively (n 6). To de-
termine whether the uptake was affected by
cell content of ATP, the effect of NaN3/dxg tre-
atment on [14C]-adenosine uptake was assess-
ed. A decrease cell radioactivity to 17 2.0%
(n 6) was found. To verify adenosine active
transport in human ®broblasts, the uptake
assays were carried out substituting extracel-
lular Na with equimolar choline, which elimi-
nates concentrative Na-dependent adenosine
permeation, or inhibiting Na, K-ATPase
by 2 mM ouabain, that dissipated the electro-
chemical gradient of Na. The effects were
less than those obtained with NaN3/dxg treat-
ment, leading to [14C]-adenosine uptakes
of 25.27 1.0 and 26.9 1.0%, respectively
(n 4). Finally, the effect of exogenous ADPri-
bose on [14C]-adenosine uptake was tested.
[14C]nucleoside transport was reduced to
19.71 3.84% of total radioactivity in the
presence of 100 mM ADPribose (n 6). This
inhibition was removed when the incubation
medium was supplemented with 1 mM a-b
methyleneADP, an inhibitor of 50-nucleotidase.
a-b methyleneADP was ineffective when incu-
bated with [14C]adenosine alone, but when
added to U-[14C]-adenine-NAD uptake assay
mixture, strongly depressed uptake (2.7
0.4%, n 2) thus demonstrating that adenosine
is the purine moiety of NAD which permeates
the cell membrane.
DISCUSSION
In a previous study, we demonstrated that
NAD-glycohydrolase (cleaving NAD into nico-
tinamide and ADPR), nucleotide pyrophospha-
tase (cleaving NAD into NMN and AMP), and
50-nucleotidase are the enzymes involved in
extracellular NAD catabolism in human skin
®broblasts. We also showed that the ®nal pro-
ducts of the extracellular NAD metabolism are
nicotinamide, NMN, hypoxanthine and ade-
nine [Aleo et al., 1996]. In the present study, we
investigated the metabolic fate of the extra-
cellular NAD purine moiety, showing that ade-
nosine is the form which permeates the cell
membrane.
This hypothesis is supported by the competi-
tion observed between ADPribose or adenosine
and [14C]-NAD for uptake of the purine moiety
into cells and by the drastic reduction in uptake
of labeled purine with an inhibitor of adenosine
transport such as DPR in the extracellular
medium. Moreover, ®broblasts incubated with
[14C]-adenosine yield the same radioactive
products as with [14C]-NAD. The fact that
ADPribose does not inhibit [14C]-adenosine
uptake in the presence of a-b methyleneADP,
an inhibitor of 50-nucleotidase, demonstrates
that ADPribose produced from NAD via NAD-
glycohydrolase is ®nally catabolised to adeno-
sine. The product of NAD degradation via
nucleotide pyrophosphatase, AMP, has the
same fate, being converted by 50 nucleotidase
into adenosine, which enters the cell. Most of
the adenosine incorporated into ®broblasts is
then phosphorylated and metabolized via AMP
to ADP and ATP (90%). The extracellular fates
of NAD suggested by our results are summar-
ized in Figure 5.
The partial inhibition of [14C]-NAD uptake
observed in ®broblasts depleted of ATP shows
that the adenosine transport system requires
ATP to some extent. The main transport of
nucleosides into the cells is known to be equi-
librative (by facilitated diffusion) or concentra-
tive (Na linked) [Dagnino et al., 1991; Gu
et al., 1996]. Adenosine kinase, which causes
phosphorylation of adenosine, plays a role in
Fig. 4. Distribution of intracellular radioactive adenine com-
pounds after incubation of human ®broblasts for 1 h with 1 mM
U-[14C]-adenosine. Values are given as percentage of total cell
extract radioactivity.
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nucleotide uptake. In our experiments with
human ®broblasts, uptake of [14C]-adenosine
was completely inhibited by DPR as well as by
NBT, known inhibitors of equilibrative nucleo-
side transport, and was partially inhibited in
ATP depleted cells, to the same extent as
previously observed for [14C]-NAD. Choline
and ouabaine, which depress Na-dependent
adenosine permeation and the electrochemical
gradient respectively, slightly inhibited uptake
of [14C]-adenosine, showing that some adeno-
sine (about 20±25% of total uptake) may enter
®broblasts by active transport.
All these ®ndings indicate that adenosine is
the main transport form of the purine moiety of
NAD, when NAD is metabolized by extracel-
lular enzymes. Passive transport of NAD was
recently demonstrated [Zocchi et al., 1999]; the
¯ux across the membranes depended only on
the concentration gradient and did not seem to
require any energy source. The cells used for
the above experiments (HeLa and 3T3 cell
lines) were previously shown to be devoid of
any NAD hydrolyzing activity. We cannot
exclude the possibility that in human ®bro-
blasts, in which NAD hydrolyzing activities do
exist, a small amount of NAD permeates the
membranes by a similar transport mechanism.
The novel ®nding demonstrated in this study
with human ®broblasts is that NAD is cleaved
by extracellular enzymes, and the purine form
which is taken up is adenosine.
ACKNOWLEDGMENTS
This work was ®nanced by the Italian
Ministry of Universities and Scienti®c and
Technological Research (MURST funds 60%).
REFERENCES
Aleo MF, Sestini S, Pompucci G, Preti A. 1996. Enzymatic
activities affecting exogenous nicotinamide adenine
dinucleotide in human skin ®broblasts. J Cell Physiol
167:173±176.
Atkinson DE. 1977. Cellular energy metabolism and its
regulation. New York: Academic Press.
Berridge MJ. 1993. A tale of two messengers. Nature 365:
388±389.
Bock KW, Siekevitz P, Palade GE. 1971. Localization and
turnover studies of membrane nicotinamide adenine
dinucleotide glycohydrolase in rat liver. J Biol Chem
38:20±24.
Bradford MM. 1976. A rapid and sensitive method for
quantitation of microgram quantities of protein utilizing
the principle of protein-dye binding. Anal Biochem 72:
248±254.
Dagnino L, Bennet LL Jr, Paterson ARP. 1991. Sodium-
dependent nucleoside transport in mouse leukemia
L1210 cells. J Biol Chem 266:6308±6311.
De Flora A, Guida L, Franco L, Zocchi E, Pestarino M, Usai
C, Marchetti C, Fedele E, Fontana G, Raiteri M. 1996.
Ectocellular in vitro and in vivo metabolism of cADP-
ribose in cerebellum. Biochem J 320:665±672.
De Flora A, Franco L, Guida L, Bruzzone S, Zocchi E. 1998.
Ectocellular CD-38 catalyzed synthesis and intracellular
Ca2-mobilizing activity of cyclic ADP-ribose. Cell Bio-
chem Biophys 28:45±62.
Gallareta M, Solis JM, Menendez N, Conejero C, Martin del
Rio R. 1993. Nicotinamide adenine dinucleotides mimic
Fig. 5. Extracellular fates of NAD in human ®broblasts.
Fate of Extracellular NAD in Human Fibroblasts 365
adenosine inhibition on synaptic transmission by decre-
asing glutamate release in rat hippocampal slices. Neuro-
science Lett 159:55±58.
Gu JG, Nath A, Geiger JD. 1996. Characterization of
inhibitor-sensitive and inhibitor-resistant adenosine
transporters in cultured human fetal astrocytes. J
Neurochem 67:972±977.
Han MK, Kim JH, Lee DG, Kim UH. 1995. Immunohisto-
chemical localization of NAD glycohydrolase in human
and rabbit tissue. Histochem Cell Biol 104:185±189.
Honma T, Mandel P. 1986. NAD glycohydrolase of the
plasmamembrane prepared from glial and neuronal cells.
J Neurochem 47:972±975.
Kato I, Takasawa S, Akabane A, Tanaka O, Abe H,
Takamura T, Suzuki Y, Nata K, et al. 1995. Regulatory
role of CD 38 (ADP-ribosyl cyclase/cyclic ADP-ribose
hydrolase) in insulin secretion by glucose in pancreatic
cells. J Biol Chem 270:30045±30050.
Kim UH, Han MK, Park BH, Kim HR, An NH. 1993a.
Function of NAD glycohydrolase in ADP-ribose uptake
from NAD by human erythrocytes. Biochim Biophys Acta
1178:121±126.
Kim H, Jacobson EL, Jacobson MK. 1993b. Synthesis and
degradation of cyclic ADP-ribose by NAD glycohydro-
lases. Science 261:1330±1333.
Lee HC, Aarhus R. 1991. ADP-ribosyl cyclase: an enzyme
that cyclizes NAD into a calcium-mobilizing metabolite.
Cell Regul 2:203±209.
Lee HC. 1994. Cyclic ADP-ribose: a new member of a
super family of signalling cyclic nucleotides. Cell Sign
6:591±600.
Malavasi F, Funaro A, Roggero S, Horenstein A, Calosso L,
Mehta K. 1994. Human CD38: a glycoprotein in search of
a function. Imm Today 15:95±97.
Majamaa K, Rusanen H, Rernes AM, Pytinen J, Hassinen
IE. 1996. Increase of blood NAD and of lactacidemia
during nicotinamide treatment of a patient with the
MELAS syndrome. Life Science 58:691±699.
Muller HM, Muller CD, Shuber F. 1983. NAD glycohy-
drolase, an ecto-enzyme of calf spleen cells. Biochem J
212:459±464.
Okamoto H, Takasawa S, Tohgo A. 1995. New aspects of the
physiological signi®cance of NAD, poly-ADPribose and
cyclic ADP-ribose. Biochimie 77:356±363.
Snell CR, Snell PH, Richards CD. 1984. Degradation of
NAD by synaptosomes and its inhibition by nicotinamide
mononucleotide: implication for the role of NAD as a
synaptic modulator. J Neurochem 43:1610±1615.
Travo P, Muller H, Shuber F. 1979. Calf spleen NAD
glycohydrolase. Comparison of the catalytic properties of
the membrane-bound and the hydrosoluble forms of the
enzyme. Eur J Biochem 96:141±149.
Ueda K, Hayaishi O. 1985. ADP-ribosylation. Annu Rev
Biochem 54:73±100.
Zimmermann H. 1996. Extracellular purine metabolism.
Drug Develop Res 39:337±352.
Zocchi E, Franco L, Guida L, Benatti U, Bargellesi A,
Malavasi F, Lee HC, De Flora A. 1993. A single protein
immunologically identi®ed as CD38 displays NAD
glycohydrolase, ADP-ribosyl cyclase and cyclic ADP-
ribose hydrolase activities at the outer surface of human
erythrocytes. Biochem Biophys Res Comm 196:1459±
1465.
Zocchi E, Usai C, Guida L, Franco L, Bruzzone S,
Passalacqua M, De Flora A. 1999. Ligand-induced inter-
nalization of CD38 results in intracellular Ca2mobiliza-
tion: role of NAD transport across cell membrane.
FASEB J 13:273±283.
366 Aleo et al.
